Multiomics study of HepG2 cell line proteome

   


1. Institute of Biomedical Chemistry, Moscow, Russia
Type: OMICS-technologies
DOI: 10.18097/PBMC20176305373      PubMed Id: 29080867
Year: 2017 vol: 63  issue:5  pages: 373-378
Abstract: Current proteomic studies are generally focused on the most abundant proteoforms encoded by canonical nucleic sequences. Transcriptomic and proteomic data, accumulated in a variety of postgenome sources and coupled with state-of-art analytical technologies, allow to start the identification of aberrant (non-canonical) proteoforms. The main sources of aberrant proteoforms are alternative splicing, single nucleotide polymorphism, and post-translational modifications. The aim of this work was to estimate the heterogeneity of HepG2 proteome. We suggested multiomics approach, which combines transcriptomic (RNAseq) and proteomic (2DE-MS/MS) methods, as a promising strategy to explore the proteome.
Download PDF:
Reference: Poverennaya E.V., Kiseleva O.I., Ponomarenko E.A., Naryzhny S.N., Zgoda V.G., Lisitsa A.V., Multiomics study of HepG2 cell line proteome, Biomeditsinskaya khimiya, 2017, vol: 63(5), 373-378.
References
 2017(Vol:63)
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)